XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common stock:
Additional paid-in-capital:
Treasury stock at cost:
Retained earnings:
Accumulated other comprehensive income:
Beginning balance at Dec. 31, 2022   $ 2 $ 17,279 $ (46,702) $ 34,315 $ 259
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Tax withholdings related to net share settlements of restricted stock units and awards     (48)      
Stock-based compensation     128      
Other     5      
Common stock repurchased       (252)    
Net income $ 567       567  
Dividends and dividend equivalents declared         (138)  
Foreign currency translation adjustment           1
Change in unrealized gains (losses) on investments 19         19
Change in unrealized gains (losses) on derivative instruments           (53)
Tax benefit (provision) on above items           5
Ending balance at Mar. 31, 2023 $ 5,387 2 17,364 (46,954) 34,744 231
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.25          
Beginning balance at Dec. 31, 2023 $ 6,396 2 17,792 (48,114) 36,531 185
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Tax withholdings related to net share settlements of restricted stock units and awards     (51)      
Stock-based compensation     146      
Other     4      
Common stock repurchased (499)     (503)    
Net income 438       438  
Dividends and dividend equivalents declared         (143)  
Foreign currency translation adjustment           (37)
Change in unrealized gains (losses) on investments 8         8
Change in unrealized gains (losses) on derivative instruments           22
Tax benefit (provision) on above items           (7)
Ending balance at Mar. 31, 2024 $ 6,273 $ 2 $ 17,891 $ (48,617) $ 36,826 $ 171
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.27